We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-8.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.03B
AUM Growth
-$263M
Cap. Flow
+$136M
Cap. Flow %
4.51%
Top 10 Hldgs %
30.94%
Holding
140
New
22
Increased
32
Reduced
18
Closed
16

Top Buys

Rank Stock Value
1
SMAR
Smartsheet Inc.
SMAR
+$46.4M
2
POOL icon
Pool Corp
POOL
+$35.7M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$34.3M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$22M
5
LII icon
Lennox International
LII
+$14.4M

Top Sells

Rank Stock Value
1
TLND
Talend S.A. American Depositary Shares
TLND
+$26.6M
2
STLD icon
Steel Dynamics
STLD
+$22.8M
3
XPO icon
XPO
XPO
+$21.4M
4
PS
Pluralsight, Inc. Class A Common Stock
PS
+$19.6M
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$16.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.23%
2 Technology 22.61%
3 Industrials 11.22%
4 Consumer Discretionary 8.19%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNCR icon
76
Xencor
XNCR
$1.59B
$10.1M 0.33%
300,000
– –
RGEN icon
77
Repligen
RGEN
$7.03B
$9.13M 0.3%
119,000
-50,000
-30% -$4.37M
ARYAU
78
DELISTED
ARYA Sciences Acquisiton Corp. Unit
ARYAU
$8.77M 0.29%
800,000
– –
STKL
79
DELISTED
SunOpta
STKL
$7.44M 0.25%
4,132,375
-168,165
-4% -$436K
HSACU
80
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$7.3M 0.24%
680,000
– –
THOR
81
DELISTED
Synthorx, Inc. Common Stock
THOR
$6.51M 0.22%
400,000
– –
EPIX
82
DELISTED
ESSA Pharma
EPIX
$6.44M 0.21%
2,010,169
+625,000
+45% +$1.54M
STSA
83
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$6.38M 0.21%
+425,000
New +$6.59M
KRTX
84
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.83M 0.16%
296,000
-840,234
-74% -$16.3M
STRO icon
85
Sutro Biopharma
STRO
$411M
$4.77M 0.16%
52,500
-71,990
-58% -$7.27M
FENC icon
86
Fennec Pharmaceuticals
FENC
$344M
$3.46M 0.11%
720,000
– –
BEP icon
87
Brookfield Renewable
BEP
$9.9B
$3.41M 0.11%
157,438
+8,256
+6% +$161K
ORTX
88
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$3.21M 0.11%
27,000
– –
ARE icon
89
Alexandria Real Estate Equities
ARE
$9.15B
$2.85M 0.09%
18,500
+1,300
+8% +$192K
NEE icon
90
NextEra Energy
NEE
$183B
$2.75M 0.09%
47,200
-2,400
-5% -$130K
DOC icon
91
Healthpeak Properties
DOC
$15.2B
$2.64M 0.09%
74,200
+12,600
+20% +$425K
OKE icon
92
Oneok
OKE
$56.1B
$2.32M 0.08%
+31,500
New +$2.23M
ETTX
93
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$2.29M 0.08%
392,513
-487,028
-55% -$3.27M
GYRE icon
94
Gyre Therapeutics
GYRE
$648M
$2.27M 0.08%
61,714
– –
WM icon
95
Waste Management
WM
$90.9B
$2.24M 0.07%
19,500
– –
EQIX icon
96
Equinix
EQIX
$103B
$2.19M 0.07%
+3,800
New +$2.04M
PLD icon
97
Prologis
PLD
$136B
$2.07M 0.07%
24,300
-1,400
-5% -$116K
TT icon
98
Trane Technologies
TT
$97.3B
$1.93M 0.06%
15,700
-4,300
-22% -$525K
FHN icon
99
First Horizon
FHN
$12.1B
$1.73M 0.06%
+106,900
New +$1.69M
FRC
100
DELISTED
First Republic Bank
FRC
$1.71M 0.06%
+17,700
New +$1.68M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Eventide Asset Management held 140 positions worth $3.03B, down 8% from $3.29B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $136M of net new capital in Q3 2019, opening 22 new positions and adding to 32 existing holdings. Its largest new stake was Smartsheet Inc.: 975,000 shares worth $35.1M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was XPO, an estimated $21.4M trimmed.

  • Eventide Asset Management's largest Q3 2019 buy was Smartsheet Inc.: 975,000 shares worth $35.1M.
  • Eventide Asset Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $34.3M increase.
  • Eventide Asset Management's biggest Q3 2019 reduction was XPO, cutting an estimated $21.4M.
  • Eventide Asset Management fully exited Talend S.A. American Depositary Shares in Q3 2019, selling an estimated $26.6M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $3.03B portfolio in Q3 2019.
  • Eventide Asset Management opened 22 new positions and closed 16 in Q3 2019.
  • Eventide Asset Management's portfolio value fell 8% quarter-over-quarter to $3.03B.

Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.